Cel-Sci
CVM
#9791
Rank
HK$0.38 B
Marketcap
HK$45.31
Share price
-1.19%
Change (1 day)
-50.31%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$95.3 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are HK$95.3 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-09-30HK$94.92 M-13.55%
2024-09-30HK$0.10 B-19.01%
2023-09-30HK$0.13 B-5.93%
2022-09-30HK$0.14 B-4.26%
2021-09-30HK$0.15 B-6.65%
2020-09-30HK$0.16 B-8.51%
2019-09-30HK$0.17 B-23.89%
2018-09-30HK$0.23 B12.92%
2017-09-30HK$0.20 B3.43%
2016-09-30HK$0.19 B-23.2%
2015-09-30HK$0.25 B278.43%
2014-09-30HK$68.22 M112.57%
2013-09-30HK$32.09 M-54.21%
2012-09-30HK$70.08 M-5.76%
2011-09-30HK$74.37 M-3.67%
2010-09-30HK$77.2 M-73.21%
2009-09-30HK$0.28 B864.3%
2008-09-30HK$29.88 M-36.53%
2007-09-30HK$47.08 M-42.9%
2006-09-30HK$82.46 M976.42%
2005-09-30HK$7.66 M-29.37%
2004-09-30HK$10.84 M-17.19%
2003-09-30HK$13.09 M-38.01%
2002-09-30HK$21.12 M433.62%
2001-09-30HK$3.95 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
HK$887.04 B 930,646.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$629.09 B 659,986.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$1.90 B 1,896.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
HK$0.33 B 247.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$254.70 B 267,157.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
HK$6.51 B 6,739.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$6.86 B 7,101.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$20.32 M-78.67%๐Ÿ‡บ๐Ÿ‡ธ USA